What's new? Log in Free sign up

Black Diamond Therapeutics (BDTX) News and press releases

Company Profile

News

From Benzinga Pro

Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Black Diamond Therapeutics Announces Spinout Of Launchpad Therapeutics, Inc., An Antibody-Focused Precision Oncology Company

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced the formation of Launchpad Therapeutics, Inc.

Black Diamond Therapeutic Q3 EPS $(0.60) Up From $(0.97) YoY

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.60) per share. This is a 38.14 percent increase over losses of $(0.97) per share from the same period last year.

Press releases

From Benzinga Pro

Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

News, Health Care, Press Releases

CAMBRIDGE, Mass. and NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage precision oncology medicine company developing MasterKey therapies designed to overcome

Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company

Health Care, Press Releases, General

- $30M Series A investment from Versant Ventures and NEA- CAMBRIDGE, Mass. and NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a precision oncology medicine company